Related references
Note: Only part of the references are listed.JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure
Hiroyuki Tsutsui et al.
JOURNAL OF CARDIAC FAILURE (2021)
Depression and heart failure: an intricate relationship
Gaetano Aloisi et al.
MONALDI ARCHIVES FOR CHEST DISEASE (2019)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Effect of Escitalopramon All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression The MOOD-HF Randomized Clinical Trial
Christiane E. Angermann et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
A dynamic view of comorbid depression and generalized anxiety disorder symptom change in chronic heart failure: the discrete effects of cognitive behavioral therapy, exercise, and psychotropic medication
Phillip J. Tully et al.
DISABILITY AND REHABILITATION (2015)
Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome: Systematic Review and Recommendations A Scientific Statement From the American Heart Association
Judith H. Lichtman et al.
CIRCULATION (2014)
Effects of exercise training on depression in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials
Rong-Hui Tu et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Meta-Analysis of Selective Serotonin Reuptake Inhibitor-Associated QTc Prolongation
Scott R. Beach et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Clyde W. Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
QT interval and antidepressant use: a cross sectional study of electronic health records
Victor M. Castro et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Collaborative care for depression and anxiety problems
Janine Archer et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: The relevance of the placebo effect and psychological symptoms
Renerio Fraguas et al.
CONTEMPORARY CLINICAL TRIALS (2009)
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
Andrea Cipriani et al.
LANCET (2009)
Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis
M. Bryant Howren et al.
PSYCHOSOMATIC MEDICINE (2009)
An overview of cardiovascular disease burden in the United States
George A. Mensah et al.
HEALTH AFFAIRS (2007)
Depression in heart failure - A meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes
Thomas Rutledge et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Depression in patients with heart failure
C Westlake et al.
JOURNAL OF CARDIAC FAILURE (2005)
Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure
SD Katz et al.
CIRCULATION (2005)
Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death
D Fischer et al.
EUROPEAN HEART JOURNAL (2005)
Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events - The Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) platelet substudy
VL Serebruany et al.
CIRCULATION (2003)
The epidemiology of major depressive disorder - Results from the National Comorbidity Survey Replication (NCS-R).
RC Kessler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities
C Sánchez et al.
PSYCHOPHARMACOLOGY (2003)
Psychoneuroimmunology of depression: Clinical implications
M Irwin
BRAIN BEHAVIOR AND IMMUNITY (2002)
Do cytokines enable risk stratification to be improved in NYHA functional class III patients? Comparison with other potential predictors of prognosis
R Kell et al.
EUROPEAN HEART JOURNAL (2002)
Depression in patients recovering from a myocardial infarction
RC Ziegelstein
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure
W Jiang et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Depressive symptoms and risk of functional decline and death in patients with heart failure
V Vaccarino et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Share Paper
